Related references
Note: Only part of the references are listed.A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells
Sonia M. Dubois et al.
BLOOD (2014)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Mechanism Underlying IκB Kinase Activation Mediated by the Linear Ubiquitin Chain Assembly Complex
Hiroaki Fujita et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
Yibin Yang et al.
CANCER DISCOVERY (2014)
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Bryan King et al.
CELL (2013)
Regulation of NF-κB by ubiquitination
Jueqi Chen et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Zhao-Hui Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells
Yoshiteru Sasaki et al.
EMBO JOURNAL (2013)
Structural Architecture of the CARMA1/Bcl10/MALT1 Signalosome: Nucleation-Induced Filamentous Assembly
Qi Qiao et al.
MOLECULAR CELL (2013)
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination
Christiane Pelzer et al.
NATURE IMMUNOLOGY (2013)
Monoubiquitination and Activity of the Paracaspase MALT1 Requires Glutamate 549 in the Dimerization Interface
Katrin Cabalzar et al.
PLOS ONE (2013)
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A
Mary Pulvino et al.
BLOOD (2012)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang et al.
CANCER CELL (2012)
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7
Kelly Verhelst et al.
EMBO JOURNAL (2012)
Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation
Fuminori Tokunaga et al.
EMBO JOURNAL (2012)
A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex
Hirokazu Yagi et al.
EMBO REPORTS (2012)
Roles of BCL6 in normal and transformed germinal center B cells
Katia Basso et al.
IMMUNOLOGICAL REVIEWS (2012)
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
A. Lopez-Girona et al.
LEUKEMIA (2012)
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Shanshan Duan et al.
NATURE (2012)
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Luca Busino et al.
NATURE CELL BIOLOGY (2012)
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency
Bertrand Boisson et al.
NATURE IMMUNOLOGY (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
Functional modulation of AMP-activated protein kinase by cereblon
Kwang Min Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu et al.
BLOOD (2011)
Higher Response to Lenalidomide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Nongerminal Center B-Cell-Like Than in Germinal Center B-Cell-Like Phenotype
Francisco J. Hernandez-Ilizaliturri et al.
CANCER (2011)
T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1
Jens Staal et al.
EMBO JOURNAL (2011)
A20: More Than One Way to Skin a Cat
Srinivasa M. Srinivasula et al.
MOLECULAR CELL (2011)
Direct, Noncatalytic Mechanism of IKK Inhibition by A20
Brian Skaug et al.
MOLECULAR CELL (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Fuminori Tokunaga et al.
NATURE (2011)
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis
Fumiyo Ikeda et al.
NATURE (2011)
Linear ubiquitination prevents inflammation and regulates immune signalling
Bjoern Gerlach et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
What Determines the Specificity and Outcomes of Ubiquitin Signaling?
Fumiyo Ikeda et al.
CELL (2010)
CYLD: a tumor suppressor deubiquitinase regulating NF-kappa B activation and diverse biological processes
S-C Sun
CELL DEATH AND DIFFERENTIATION (2010)
The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
Rita M. Tavares et al.
IMMUNITY (2010)
Temporal and Spatial Mouse Brain Expression of Cereblon, An Ionic Channel Regulator Involved in Human Intelligence
Joseph J. Higgins et al.
JOURNAL OF NEUROGENETICS (2010)
Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
Ivan Bosanac et al.
MOLECULAR CELL (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
K. M. Crusio et al.
ONCOGENE (2010)
HOIL-1L Interacting Protein (HOIP) as an NF-κB Regulating Component of the CD40 Signaling Complex
Bruce S. Hostager et al.
PLOS ONE (2010)
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito et al.
SCIENCE (2010)
Signaling to NF-κB: Regulation by Ubiquitination
Ingrid E. Wertz et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Oncogenic Activation of NF-kappa B
Louis M. Staudt
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Antigen Receptor Signaling to NF-κB via CARMA1, BCL10, and MALT1
Margot Thome et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
A20: from ubiquitin editing to tumour suppression
Sarah G. Hymowitz et al.
NATURE REVIEWS CANCER (2010)
Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
Simin Rahighi et al.
CELL (2009)
Cereblon is expressed in the retina and binds to voltage-gated chloride channels
Bettina Hohberger et al.
FEBS LETTERS (2009)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Roland Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells
Uta Ferch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction
Tobias L. Haas et al.
MOLECULAR CELL (2009)
Ubiquitylation in innate and adaptive immunity
Vijay G. Bhoj et al.
NATURE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Fuminori Tokunaga et al.
NATURE CELL BIOLOGY (2009)
Building ubiquitin chains: E2 enzymes at work
Yihong Ye et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys(63)-linked polyubiquitination of IRAK1
Alban Ordureau et al.
BIOCHEMICAL JOURNAL (2008)
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies
Kim Newton et al.
CELL (2008)
Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex
Lingyan Jin et al.
CELL (2008)
Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20
Su-Chang Lin et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and Toll-like receptor-mediated NF-κB activation
Dietrich B. Conze et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20
Beatrice Coornaert et al.
NATURE IMMUNOLOGY (2008)
The proteolytic activity of the paracaspase MALT1 is key in T cell activation
Fabien Rebeaud et al.
NATURE IMMUNOLOGY (2008)
NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation
Chuan-Jin Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation
Andrea Oeckinghaus et al.
EMBO JOURNAL (2007)
Genotoxic stress regulates expression of the proto-oncogene Bc16 in germinal center B cells
Ryan T. Phan et al.
NATURE IMMUNOLOGY (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Benjamin J. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Richard S. Maser et al.
NATURE (2007)
Structure of a Fbw7-Skp1-cyclin E complex: Multisite-phosphorylated substrate recognition by SCF ubiquitin ligases
Bing Hao et al.
MOLECULAR CELL (2007)
Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells
J. Liu et al.
ONCOGENE (2007)
TAK1-dependent signaling requires functional interaction with TAB2/TAB3
Arnaud Besse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation
Betty Lamothe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A fourth IκB protein within the NF-κB signaling module
Soumen Basak et al.
CELL (2007)
FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions
Trijnie Dijkhuizen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation
Leigh Ann Higa et al.
NATURE CELL BIOLOGY (2006)
DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases
Yizhou Joseph He et al.
GENES & DEVELOPMENT (2006)
A ubiquitin ligase complex assembles linear polyubiquitin chains
Takayoshi Kirisako et al.
EMBO JOURNAL (2006)
A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1
Jianping Jin et al.
MOLECULAR CELL (2006)
PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum
Stephen S. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
Lineage dependency and lineage-survival oncogenes in human cancer
Levi A. Garraway et al.
NATURE REVIEWS CANCER (2006)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A loss-of-function RNA interference screen for molecular targets in cancer
VN Ngo et al.
NATURE (2006)
Posttranslational modifications of Bcl2 family members - a potential therapeutic target for human malignancy
A Basu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
Mechanisms of tumor suppression by the SCFFbw7
AC Minella et al.
CELL CYCLE (2005)
Regulation of the cell cycle by SCF-type ubiquitin ligases
KI Nakayama et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain
S Jo et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Ubiquitin interactions of NZF zinc fingers
SL Alam et al.
EMBO JOURNAL (2004)
The novel functions of ubiquitination in signaling
LJ Sun et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation
JJ Higgins et al.
NEUROLOGY (2004)
Systematic analysis and nomenclature of mammalian F-box proteins
JP Jin et al.
GENES & DEVELOPMENT (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes
LJ Sun et al.
MOLECULAR CELL (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
TR Brummelkamp et al.
NATURE (2003)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
A Kovalenko et al.
NATURE (2003)
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
E Trompouki et al.
NATURE (2003)
TNF-receptor-associated factors as targets for drug development
JM Zapata
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase
S Orlicky et al.
CELL (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
C Hoege et al.
NATURE (2002)
Requirement of RAD5 and MMS2 for postreplication repair of UV-damaged DNA in Saccharomyces cerevisiae
CA Torres-Ramos et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells
P Dhawan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A gene for nonsyndromic mental retardation maps to chromosome 3p25-pter
JJ Higgins et al.
NEUROLOGY (2000)
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway
K Breitschopf et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Recognition of the polyubiquitin proteolytic signal
JS Thrower et al.
EMBO JOURNAL (2000)
Share Paper
